Platelet and Plasma Market Size By Component (Platelets, Plasma), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Distribution Channel (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

Report Content

Chapter 1.  Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters    

1.4. Data Sources

1.4.1.  Secondary

1.4.1.1.  Paid sources

1.4.1.2.    Unpaid sources

1.4.2.  Primary

Chapter 2.  Executive Summary

2.1. Platelet and plasma industry 360⁰ synopsis, 2015 – 2026

2.1.1.  Business trends

2.1.2.  Component trends

2.1.3.  Application trends

2.1.4.  Distribution channel trends

2.1.5.  Regional trends

Chapter 3.  Platelet and Plasma Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry ecosystem

3.3.1.  Value chain analysis

3.3.2.  Distribution channel analysis

3.4. Industry impact forces

3.4.1.  Growth drivers

3.4.1.1. Higher number of blood transfusions in Europe

3.4.1.2. Recent advances in therapeutic protein drug development

3.4.1.3. Increasing prevalence of liver diseases in elderly population

3.4.1.4. Exclusive use of plasma for treatment of rare diseases in Europe

3.4.1.5. Fair reimbursement in developed countries

3.4.2.  Industry pitfalls & challenges

3.4.2.1. Stringent regulatory policies

3.4.2.2. Affordability issue in APAC and Latin America due to high costs

3.5. Growth potential analysis

3.5.1.  By component

3.5.2.  By application

3.5.3.  By distribution channel

3.6. COVID-19 impact analysis

3.7. Porter’s analysis

3.8. PESTEL analysis

Chapter 4.  Platelet and Plasma Market, By Component

4.1. Key segment trends

4.2. Platelets

4.2.1.  Market size, by region, 2015 – 2026 (USD Million)

4.3. Plasma

4.3.1.  Market size, by region, 2015 – 2026 (USD Million)

Chapter 5.  Platelet and plasma Market, By Application

5.1. Key segment trends

5.2. Hemophilia

5.2.1.  Market size, by region, 2015-2026 (USD Million)

5.3. Thrombocytopenia

5.3.1.  Market size, by region, 2015-2026 (USD Million)

5.4. Perioperative indications

5.4.1.  Market size, by region, 2015-2026 (USD Million)

5.5. Platelet function disorders

5.5.1.  Market size, by region, 2015-2026 (USD Million)

5.6. Other platelet applications

5.6.1.  Market size, by region, 2015-2026 (USD Million)

5.7. Coagulation factor deficiencies

5.7.1.  Market size, by region, 2015-2026 (USD Million)

5.8. Thrombotic thrombocytopenic purpura

5.8.1.  Market size, by region, 2015-2026 (USD Million)

5.9. Hemorrhage

5.9.1.  Market size, by region, 2015-2026 (USD Million)

5.10.  Liver disease

5.10.1.   Market size, by region, 2015-2026 (USD Million)

5.11.  Other plasma applications

5.11.1.   Market size, by region, 2015-2026 (USD Million)

Chapter 6.  Platelet and Plasma Market, By Distribution Channel

6.1. Key segment trends

6.2. Hospitals

6.2.1.  Market size, by region, 2015 – 2026 (USD Million)

6.3. Ambulatory surgical centers

6.3.1.  Market size, by region, 2015 – 2026 (USD Million)

6.4. Others

6.4.1.  Market size, by region, 2015 – 2026 (USD Million)

Chapter 7.  Platelet and plasma Market, By Region

7.1. Platelet and plasma market share, by region, 2017 & 2024

7.2. North America

7.2.1.  Market size, by country, 2015 – 2026 (USD Million)

7.2.2.  Market size, by component, 2015 – 2026 (USD Million)

7.2.3.  Market size, by application, 2015 – 2026 (USD Million)

7.2.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.2.5.  U.S.

7.2.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.2.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.2.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.2.6.  Canada

7.2.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.2.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.2.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3. Europe

7.3.1.  Market size, by country, 2015 – 2026 (USD Million)

7.3.2.  Market size, by component, 2015 – 2026 (USD Million)

7.3.3.  Market size, by application, 2015 – 2026 (USD Million)

7.3.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.5. Germany

7.3.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.6. UK

7.3.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.7. France

7.3.7.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.7.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.7.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.8. Italy

7.3.8.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.8.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.8.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.9. Spain

7.3.9.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.9.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.9.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4. Asia Pacific

7.4.1. Market size, by country, 2015 – 2026 (USD Million)

7.4.2.  Market size, by component, 2015 – 2026 (USD Million)

7.4.3.  Market size, by application, 2015 – 2026 (USD Million)

7.4.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4.5. Japan

7.4.5.1. Market size, by component, 2015 – 2026 (USD Million)

7.4.5.2. Market size, by application, 2015 – 2026 (USD Million)

7.4.5.3.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4.6. China

7.4.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.4.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.4.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4.7. India

7.4.7.1.  Market size, by component, 2015 – 2026 (USD Million)

7.4.7.2.    Market size, by application, 2015 – 2026 (USD Million)

7.4.7.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.5. Latin America

7.5.1.  Market size, by country, 2015 – 2026 (USD Million)

7.5.2.  Market size, by component, 2015 – 2026 (USD Million)

7.5.3.  Market size, by application, 2015 – 2026 (USD Million)

7.5.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.5.5. Brazil

7.5.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.5.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.5.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.5.6. Mexico

7.5.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.5.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.5.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.6. Middle East and Africa

7.6.1.  Market size, by country, 2015 – 2026 (USD Million)

7.6.2.  Market size, by component, 2015 – 2026 (USD Million)

7.6.3.  Market size, by application, 2015 – 2026 (USD Million)

7.6.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.6.5. South Africa

7.6.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.6.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.6.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.6.6. Saudi Arabia

7.6.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.6.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.6.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

Chapter 8.  Company Profiles     

8.1. Strategy Dashboard

8.2. America’s Blood Centers

8.2.1.  Business overview

8.2.2.  Financial data

8.2.3.  Product landscape

8.2.4.  Strategic outlook

8.2.5.  SWOT analysis

8.3. American Red Cross

8.3.1.  Business overview

8.3.2.  Financial data

8.3.3.  Product landscape

8.3.4.  Strategic outlook

8.3.5.  SWOT analysis

8.4. American Association of Blood Banks

8.4.1.  Business overview

8.4.2.  Financial data

8.4.3.  Product landscape

8.4.4.  Strategic outlook

8.4.5.  SWOT analysis

8.5. Blood Centers of America

8.5.1.  Business overview

8.5.2.  Financial data

8.5.3.  Product landscape

8.5.4.  Strategic outlook

8.5.5.  SWOT analysis

8.6. European Blood Alliance

8.6.1.  Business overview

8.6.2.  Financial data

8.6.3.  Product landscape

8.6.4.  Strategic outlook

8.6.5.  SWOT analysis

8.7. Indian Red Cross

8.7.1.  Business overview

8.7.2.  Financial data

8.7.3.  Product landscape

8.7.4.  Strategic outlook

8.7.5.  SWOT analysis

8.8. Italian Red Cross

8.8.1.  Business overview

8.8.2.  Financial data

8.8.3.  Product landscape

8.8.4.  Strategic outlook

8.8.5.  SWOT analysis

8.9. Japanese Red Cross

8.9.1.  Business overview

8.9.2.  Financial data

8.9.3.  Product landscape

8.9.4.  Strategic outlook

8.9.5.  SWOT analysis

8.10.  South African Red Cross Society

8.10.1.   Business overview

8.10.2.    Financial data

8.10.3.    Product landscape

8.10.4.    Strategic outlook

8.10.5.    SWOT analysis

8.11.  OneBlood

8.11.1.   Business overview

8.11.2.    Financial data

8.11.3.    Product landscape

8.11.4.    Strategic outlook

8.11.5.    SWOT analysis